NCT04123288View on ClinicalTrials.gov

A Study to Compare a Single-dose of Two Different Formulations of ACT-709478 in Healthy Men

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 16, 2019

Primary Completion Date

February 5, 2020

Study Completion Date

February 5, 2020

Conditions
Healthy Subjects
Interventions
DRUG

ACT-709478

1 film-coated minitablet contains 2 mg of ACT-709478

DRUG

ACT-709478

1 hard capsule contains 10 mg of ACT-709478.

Trial Locations (1)

323 00

CEPHA s.r.o., Pilsen

Sponsors
All Listed Sponsors
lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY